The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli to treat Cerebrotendinous Xanthoma, a very rare lipid-storage disease. The approval makes Ctexli, or chenopod, the first ...
A man in his 40s experienced "asymptomatic yellowish nodules on his palms, soles, and elbows" for three weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback